Loring Wolcott & Coolidge Fiduciary Advisors’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$822K Sell
9,709
-605
-6% -$48.6K 0.01% 197
2026
Q1
$865K Buy
10,314
+325
+3% +$24.5K 0.01% 180
2025
Q4
$729K Buy
9,989
+307
+3% +$19.8K 0.01% 200
2025
Q3
$615K Sell
9,682
-730
-7% -$52.9K 0.01% 223
2025
Q2
$776K Sell
10,412
-1,432
-12% -$95.4K 0.01% 174
2025
Q1
$723K Sell
11,844
-3,565
-23% -$220K 0.01% 178
2024
Q4
$993K Sell
15,409
-435
-3% -$25.7K 0.01% 165
2024
Q3
$963K Sell
15,844
-5,747
-27% -$314K 0.01% 170
2024
Q2
$1.17M Sell
21,591
-2,508
-10% -$138K 0.01% 144
2024
Q1
$1.33M Sell
24,099
-4,534
-16% -$234K 0.01% 133
2023
Q4
$1.3M Hold
28,633
0.01% 138
2023
Q3
$1.42M Sell
28,633
-5,403
-16% -$286K 0.02% 129
2023
Q2
$1.95M Sell
34,036
-3,089
-8% -$180K 0.02% 116
2023
Q1
$2.24M Sell
37,125
-3,442
-8% -$210K 0.03% 110
2022
Q4
$2.38M Sell
40,567
-551
-1% -$34.9K 0.03% 104
2022
Q3
$2.35M Sell
41,118
-845
-2% -$49.2K 0.03% 104
2022
Q2
$2.27M Sell
41,963
-5,205
-11% -$302K 0.03% 106
2022
Q1
$2.71M Sell
47,168
-85
-0.2% -$4.34K 0.03% 108
2021
Q4
$2.23M Buy
47,253
+11,410
+32% +$520K 0.02% 120
2021
Q3
$1.51M Sell
35,843
-99
-0.3% -$4.28K 0.01% 140
2021
Q2
$1.59M Buy
35,942
+28,117
+359% +$1.3M 0.02% 144
2021
Q1
$365K Sell
7,825
-3,811
-33% -$169K ﹤0.01% 236
2020
Q4
$451K Sell
11,636
-802
-6% -$28.7K 0.01% 214
2020
Q3
$358K Hold
12,438
﹤0.01% 220
2020
Q2
$333K Sell
12,438
-4,465
-26% -$116K ﹤0.01% 208
2020
Q1
$397K Sell
16,903
-3,724
-18% -$102K 0.01% 186
2019
Q4
$610K Buy
20,627
+739
+4% +$19.6K 0.01% 187
2019
Q3
$557K Sell
19,888
-1,918
-9% -$55.5K 0.01% 190
2019
Q2
$645K Buy
+21,806
New +$587K 0.01% 179

Other funds holding CTVA

Loring Wolcott & Coolidge Fiduciary Advisors's CTVA Position: Q2 2026 in Review

Loring Wolcott & Coolidge Fiduciary Advisors reduced its Corteva (CTVA) stake by 5.9% in Q2 2026, selling an estimated $48.6K and leaving 9,709 shares worth $822K. The position accounts for 0.01% of the portfolio, ranked #197.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in CTVA in Q2 2019 and has held it in 29 quarters since. The position peaked at $2.71M in Q1 2022. 891 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Loring Wolcott & Coolidge Fiduciary Advisors held 9,709 shares of Corteva worth $822K as of Q2 2026.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 605 Corteva shares in Q2 2026, an estimated $48.6K.
  • Corteva made up 0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #197 holding.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Corteva in Q2 2019 and has held it in 29 quarters since.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Corteva position peaked at $2.71M in Q1 2022.
  • 891 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.